The oncogenic alternative TrkAIII splice variant (GeneBank OP866787.1) is characterized by NTRK1/TrkA exons 6, 7, and 9 skipping, and it was first identified in human NBs in association with post-therapeutic relapse and advanced-stage metastatic disease [25,28]. Here, NTRK1 is linked to Nijmegen breakage syndrome.